7 employees
Parallel Bio develops tools that help in the discovery and development of immunotherapies.
2021
$4.3M
from 4 investors over 4 rounds
Parallel Bio raised $4.3M on December 20, 2022
Investors: Breakout Ventures and Refactor Capital
Parallel Bio raised $325K on August 30, 2021
Investors: Y Combinator and Undeterred Capital